FRANCISCO JAVIER ACEBEDO MARTÍNEZ

Mr. FRANCISCO JAVIER ACEBEDO MARTÍNEZ

Laboratory of Crystallographic Studies. CSIC
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
FRANCISCO JAVIER ACEBEDO MARTÍNEZFRANCISCO JAVIER ACEBEDO MARTÍNEZ
FRANCISCO JAVIER ACEBEDO MARTÍNEZ
CACarolina Alarcón-Payer
Carolina Alarcón-Payer
Antonio FronteraAntonio Frontera
Antonio Frontera
RBRafa Barbas
Rafa Barbas
Rafel ProhensRafel Prohens
Rafel Prohens
Duane Choquesillo-LazarteDuane Choquesillo-Lazarte
Duane Choquesillo-Lazarte
Any time the pharmaceutical industry develops a new drug, potential polymorphic events must be thoroughly described, because in a crystalline pharmaceutical solid, different arrangements of the same active pharmaceutical ingredient can yield to very different physicochemical properties that might be crucial for its efficacy, such as dissolution, solubility, or stability. Polymorphism in cocrystal formulation cannot be neglected, either. In this work, two different cocrystal polymorphs of the non-steroidal anti-inflammatory drug niflumic acid and caffeine are reported. They have been synthesized by mechanochemical methods and thoroughly characterized in solid-state by powder and single crystal X-ray diffraction respectively, as well as other techniques such as thermal analyses, infrared spectroscopy and computational methods. Both theoretical and experimental results are in agreement, confirming a conformational polymorphism. The polymorph NIF–CAF Form I exhibits improved solubility and dissolution rate compared to NIF–CAF Form II, although Form II is significantly more stable than Form I. The conditions needed to obtain these polymorphs and their transition have been carefully characterized, revealing an intricate system.

7 April 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Jaime Gómez MoralesJaime Gómez Morales
Jaime Gómez Morales
RFRaquel Fernandez
Raquel Fernandez
FRANCISCO JAVIER ACEBEDO MARTÍNEZFRANCISCO JAVIER ACEBEDO MARTÍNEZ
FRANCISCO JAVIER ACEBEDO MARTÍNEZ
IRIsmael Romero-Castillo
Ismael Romero-Castillo
Cristobal Verdugo-EscamillaCristobal Verdugo-Escamilla
Cristobal Verdugo-Escamilla
Houria BoulaizHouria Boulaiz
Houria Boulaiz
This work explores the preparation of luminescent and biomimetic Tb3+-doped citrate-functionalized carbonated apatite nanoparticles. These nanoparticles were synthesized employing a citrate-based thermal decomplexing precipitation method, testing a nominal Tb3+ doping concentration between 0.001 M to 0.020 M, and a maturation time from 4 h to 7 days. This approach allowed to prepare apatite nanoparticles as a single hydroxyapatite phase when the used Tb3+ concentrations were (i) ≤ 0.005 M at all maturation times or (ii) = 0.010 M with 4 h of maturation. At higher Tb3+ concentrations, amorphous TbPO4·nH2O formed at short maturation times, while materials consisting of a mixture of carbonated apatite prisms, TbPO4·H2O (rhabdophane) nanocrystals, and an amorphous phase formed at longer times. The Tb3+ content of the samples reached a maximum of 21.71 wt%. The relative luminescence intensity revealed an almost linear dependence with Tb3+ up to a maximum of 850 units. Neither pH, nor ionic strength, nor temperature significantly affected the luminescence properties. All precipitates were cytocompatible against A375, MCF7, and HeLa carcinogenic cells, and also against healthy fibroblast cells. Moreover, the luminescence properties of these nanoparticles allowed to visualize their intracellular cytoplasmic uptake at 12 h of treatment through flow cytometry and fluorescence confocal microscopy (green fluorescence) when incubated with A375 cells. This demonstrates for the first time the potential of these materials as nanophosphors for living cell imaging compatible with flow cytometry and fluorescence confocal microscopy without the need to introduce an additional fluorescence dye. Overall, our results demonstrated that Tb3+-doped citrate-functionalized apatite nanoparticles are excellent candidates for bioimaging applications.

Verified
Journal Article
Open access
PDF file
FRANCISCO JAVIER ACEBEDO MARTÍNEZFRANCISCO JAVIER ACEBEDO MARTÍNEZ
FRANCISCO JAVIER ACEBEDO MARTÍNEZ
Alicia Dominguez-MartinAlicia Dominguez-Martin
Alicia Dominguez-Martin
CACarolina Alarcón-Payer
Carolina Alarcón-Payer
ASAlejandro Sevillano-Páez
Alejandro Sevillano-Páez
Cristobal Verdugo-EscamillaCristobal Verdugo-Escamilla
Cristobal Verdugo-Escamilla
Duane Choquesillo-LazarteDuane Choquesillo-Lazarte
Duane Choquesillo-Lazarte
Drug–drug salts are a kind of pharmaceutical multicomponent solid in which the two co-existing components are active pharmaceutical ingredients (APIs) in their ionized forms. This novel approach has attracted great interest in the pharmaceutical industry since it not only allows concomitant formulations but also has proved potential to improve the pharmacokinetics of the involved APIs. This is especially interesting for those APIs that have relevant dose-dependent secondary effects, such as non-steroidal anti-inflammatory drugs (NSAIDs). In this work, six multidrug salts involving six different NSAIDs and the antibiotic ciprofloxacin are reported. The novel solids were synthesized using mechanochemical methods and comprehensively characterized in the solid state. Moreover, solubility and stability studies, as well as bacterial inhibition assays, were performed. Our results suggest that our drug–drug formulations enhanced the solubility of NSAIDs without affecting the antibiotic efficacy.

27 November 2020 in Crystals
Verified
Journal Article
Open access
PDF file
Cristobal Verdugo-EscamillaCristobal Verdugo-Escamilla
Cristobal Verdugo-Escamilla
CACarolina Alarcón-Payer
Carolina Alarcón-Payer
Antonio FronteraAntonio Frontera
Antonio Frontera
FRANCISCO JAVIER ACEBEDO MARTÍNEZFRANCISCO JAVIER ACEBEDO MARTÍNEZ
FRANCISCO JAVIER ACEBEDO MARTÍNEZ
Alicia Dominguez-MartinAlicia Dominguez-Martin
Alicia Dominguez-Martin
Duane Choquesillo-LazarteDuane Choquesillo-Lazarte
Duane Choquesillo-Lazarte
The design of new multicomponent pharmaceutical materials that involve different active pharmaceutical ingredients (APIs), e.g., drug-drug cocrystals, is a novel and interesting approach to address new therapeutic challenges. In this work, the hydrochlorothiazide-caffeine (HCT–CAF) codrug and its methanol solvate have been synthesized by mechanochemical methods and thoroughly characterized in the solid state by powder and single crystal X-ray diffraction, respectively, as well as differential scanning calorimetry, thermogravimetric analyses and infrared spectroscopy. In addition, solubility and stability studies have also been performed looking for improved physicochemical properties of the codrug. Interestingly, the two reported structures show great similarity, which allows conversion between them. The desolvated HCT–CAF cocrystal shows great stability at 24 h and an enhancement of solubility with respect to the reference HCT API. Furthermore, the contribution of intermolecular forces on the improved physicochemical properties was evaluated by computational methods showing strong and diverse H-bond and π–π stacking interactions.

2 November 2021 in Crystals
Verified
Journal Article
Open access
PDF file
FRANCISCO JAVIER ACEBEDO MARTÍNEZFRANCISCO JAVIER ACEBEDO MARTÍNEZ
FRANCISCO JAVIER ACEBEDO MARTÍNEZ
CACarolina Alarcón-Payer
Carolina Alarcón-Payer
LRLucía Rodríguez-Domingo
Lucía Rodríguez-Domingo
Alicia Dominguez-MartinAlicia Dominguez-Martin
Alicia Dominguez-Martin
Jaime Gómez MoralesJaime Gómez Morales
Jaime Gómez Morales
Duane Choquesillo-LazarteDuane Choquesillo-Lazarte
Duane Choquesillo-Lazarte
The design of drug–drug multicomponent pharmaceutical solids is one the latest drug development approaches in the pharmaceutical industry. Its purpose is to modulate the physicochemical properties of active pharmaceutical ingredients (APIs), most of them already existing in the market, achieving improved bioavailability properties, especially on oral administration drugs. In this work, our efforts are focused on the mechanochemical synthesis and thorough solid-state characterization of two drug–drug cocrystals involving furosemide and two different non-steroidal anti-inflammatory drugs (NSAIDs) commonly prescribed together: ethenzamide and piroxicam. Besides powder and single crystal X-ray diffraction, infrared spectroscopy and thermal analysis, stability, and solubility tests were performed on the new solid materials. The aim of this work was evaluating the physicochemical properties of such APIs in the new formulation, which revealed a solubility improvement regarding the NSAIDs but not in furosemide. Further studies need to be carried out to evaluate the drug–drug interaction in the novel multicomponent solids, looking for potential novel therapeutic alternatives.

29 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
FRANCISCO JAVIER ACEBEDO MARTÍNEZFRANCISCO JAVIER ACEBEDO MARTÍNEZ
FRANCISCO JAVIER ACEBEDO MARTÍNEZ
Alicia Dominguez-MartinAlicia Dominguez-Martin
Alicia Dominguez-Martin
CACarolina Alarcón-Payer
Carolina Alarcón-Payer
CBCarolina Garcés Bastida
Carolina Garcés Bastida
Cristobal Verdugo-EscamillaCristobal Verdugo-Escamilla
Cristobal Verdugo-Escamilla
Duane Choquesillo-LazarteDuane Choquesillo-Lazarte
Duane Choquesillo-Lazarte
According to the World Health Organization, more than 422 million people worldwide have diabetes. The most common oral treatment for type 2 diabetes is the drug metformin (MTF), which is usually formulated as a hydrochloride to achieve higher water solubility. However, this drug is also highly hygroscopic, thus showing stability problems. Another kind of worldwide prescribed drug is the non-steroidal anti-inflammatory drug (NSAID). These latter, on the contrary, show a low solubility profile; therefore, they must be administered at high doses, which increases the probability of secondary effects. In this work, novel drug-drug pharmaceutical solids combining MTF-NSAIDs have been synthesized in solution or by mechanochemical methods. The aim of this concomitant treatment is to improve the physicochemical properties of the parent active pharmaceutical ingredients. After a careful solid-state characterization along with solubility and stability studies, it can be concluded that the new molecular salt formulations enhance not only the stability of MTF but also the solubility of NSAIDs, thus giving promising results regarding the development of these novel pharmaceutical multicomponent solids.